Acute chest syndrome in adult patients with sickle cell disease: The relationship with the time to onset after hospital admission

Data on acute chest syndrome (ACS) in adult sickle cell disease patients are scarce. In this study, we describe 105 consecutive ACS episodes in 81 adult patients during a 32-month period and compare the characteristics as a function of the time to onset after hospital admission for a vaso-occlusive crisis (VOC), that is early-onset episodes (time to onset ≤24 h, 42%) versus secondary episodes (>24 h, 58%; median [interquartile range] time to onset: 2 [2-3] days). The median age was 27 [22-34] years, 89% of the patients had an S/S or S/β0 -thalassaemia genotype; 81% of the patients had a history of ACS (median: 3 [2-5] per patient), only 61% were taking a disease-modifying treatment at the time of the ACS. Fever and chest pain were noted in respectively 54% and 73% of the episodes. Crackles (64%) and bronchial breathing (32%) were the main abnormal auscultatory findings. A positive microbiological test was found for 20% of episodes. Fifty percent of the episodes required a blood transfusion; ICU transfer and mortality rates were respectively 29% and 1%. Secondary and early-onset forms of ACS did not differ significantly. Disease-modifying treatments should be revaluated after each ACS episode because the recurrence rate is high.

[1]  J. Pouchot,et al.  [Acute chest syndrome in adult sickle cell patients]. , 2022, La Revue de medecine interne.

[2]  V. Gordeuk,et al.  Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection , 2021, Blood Advances.

[3]  E. Audureau,et al.  Molecular testing for respiratory pathogens in sickle cell disease adult patients presenting with febrile acute chest syndrome , 2019, Médecine et Maladies Infectieuses.

[4]  J. Pouchot,et al.  Comparison between Adult Patients with Sickle Cell Disease of Sub-Saharan African Origin Born in Metropolitan France and in Sub-Saharan Africa , 2019, Journal of clinical medicine.

[5]  J. Pouchot,et al.  Trajectories of Biological Values and Vital Parameters: An Observational Cohort Study of Adult Patients with Sickle Cell Disease Hospitalized for a Non-Complicated Vaso-Occlusive Crisis , 2019, Journal of clinical medicine.

[6]  A. Hulin,et al.  Profound underdosing of &bgr;-lactams in patients with sickle-cell disease , 2018, The Journal of antimicrobial chemotherapy.

[7]  M. DeBaun,et al.  A case series describing causes of death in pregnant women with sickle cell disease in a low‐resource setting , 2018, American journal of hematology.

[8]  Sana Abdulaziz Al Khawaja,et al.  Predictors of mortality in adults with Sickle cell disease admitted to intensive care unit in Bahrain , 2017, Journal of critical care.

[9]  J. Deux,et al.  A clinical risk score for pulmonary artery thrombosis during acute chest syndrome in adult patients with sickle cell disease , 2017, British journal of haematology.

[10]  B. Biemond,et al.  Inflammatory and endothelial markers during vaso‐occlusive crisis and acute chest syndrome in sickle cell disease , 2017, American journal of hematology.

[11]  F. Roudot-thoraval,et al.  Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients , 2016, EBioMedicine.

[12]  J. Dubois-Randé,et al.  Haematological determinants of cardiac involvement in adults with sickle cell disease. , 2016, European Heart Journal.

[13]  V. Gordeuk,et al.  Platelets decline during Vaso‐occlusive crisis as a predictor of acute chest syndrome in sickle cell disease , 2015, American journal of hematology.

[14]  V. Gordeuk,et al.  Blood transfusion and 30‐day readmission rate in adult patients hospitalized with sickle cell disease crisis , 2015, Transfusion.

[15]  M. Sarkar,et al.  Auscultation of the respiratory system , 2015, Annals of thoracic medicine.

[16]  N. Hart,et al.  Guideline on the management of acute chest syndrome in sickle cell disease , 2015, British journal of haematology.

[17]  F. Lionnet,et al.  [French guidelines for the management of adult sickle cell disease: 2015 update]. , 2015, La Revue de medecine interne.

[18]  M. Gladwin,et al.  Risk Factors for Death in 632 Patients with Sickle Cell Disease in the United States and United Kingdom , 2014, PloS one.

[19]  R. Girot,et al.  Outcomes of Adult Patients With Sickle Cell Disease Admitted to the ICU: A Case Series* , 2014, Critical care medicine.

[20]  S. Ballas,et al.  Treatment of the acute sickle cell vaso‐occlusive crisis in the Emergency Department: a Brazilian method of switching from intravenous to oral morphine , 2014, European journal of haematology.

[21]  C. Quinn,et al.  Burden of diagnostic radiation exposure in children with sickle cell disease , 2014, Pediatric blood & cancer.

[22]  H. Ebili,et al.  Autopsy findings and pattern of mortality in Nigerian sickle cell disease patients , 2014, The Pan African medical journal.

[23]  V. Allareddy,et al.  Outcomes of Acute Chest Syndrome in Adult Patients with Sickle Cell Disease: Predictors of Mortality , 2014, PloS one.

[24]  Michael J. Gilchrist,et al.  Hospitalist Management of Vaso-Occlusive Pain Crisis in Patients With Sickle Cell Disease Using a Pathway of Care , 2014, Hospital practice.

[25]  A. Rahmouni,et al.  Lung imaging during acute chest syndrome in sickle cell disease: computed tomography patterns and diagnostic accuracy of bedside chest radiograph , 2013, Thorax.

[26]  O. Steichen,et al.  High lactate dehydrogenase levels at admission for painful vaso-occlusive crisis is associated with severe outcome in adult SCD patients. , 2012, Clinical biochemistry.

[27]  A. Rahmouni,et al.  Pulmonary artery thrombosis during acute chest syndrome in sickle cell disease. , 2011, American journal of respiratory and critical care medicine.

[28]  B. Biemond,et al.  Patient‐controlled analgesia versus continuous infusion of morphine during vaso‐occlusive crisis in sickle cell disease, a randomized controlled trial , 2007, American journal of hematology.

[29]  O. Castro,et al.  Circumstances of death in adult sickle cell disease patients , 2006, American journal of hematology.

[30]  Cage S. Johnson,et al.  Outcome of Sickle Cell Anemia: A 4-Decade Observational Study of 1056 Patients , 2005, Medicine.

[31]  S. Babu,et al.  Clinical presentation of acute chest syndrome in sickle cell disease , 2004, Postgraduate Medical Journal.

[32]  P. V. Ichinsky,et al.  Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease , 2000 .

[33]  F. Roudot-thoraval,et al.  Acute chest syndrome in adults with sickle cell disease. , 2000, Chest.

[34]  O. Castro,et al.  Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. , 1997, Blood.

[35]  D. Brooks,et al.  Interrater reliability of auscultation of breath sounds among physical therapists. , 1995, Physical therapy.

[36]  J. Haynes,et al.  The acute chest syndrome of sickle cell disease. , 1993, The American journal of the medical sciences.

[37]  J. Bass,et al.  Results of bronchoscopically obtained lower airway cultures from adult sickle cell disease patients with the acute chest syndrome. , 1991, The American journal of medicine.

[38]  S. Davies,et al.  ACUTE CHEST SYNDROME IN SICKLE-CELL DISEASE , 1984, The Lancet.

[39]  E. Barrett-Connor Pneumonia and pulmonary infarction in sickle cell anemia. , 1973, JAMA.

[40]  M. Margolies SICKLE CELL ANEMIA: A Composite Study and Survey , 1951, Medicine.